Working… Menu
Trial record 1 of 1 for:    NCT03922321
Previous Study | Return to List | Next Study

Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy ( GO )

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03922321
Recruitment Status : Completed
First Posted : April 19, 2019
Last Update Posted : May 28, 2021
Information provided by (Responsible Party):
Immunovant Sciences GmbH

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 29, 2020
Actual Study Completion Date : May 21, 2020
Certification/Extension First Submitted : May 10, 2021
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 September 22, 2021